Rhythm Pharmaceuticals, Inc. (RYTM)

Last Closing Price: 116.80 (2026-11-19)

Income after Taxes (Quarterly)

Income after Taxes: Earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.

Rhythm Pharmaceuticals, Inc. (RYTM) had Income after Taxes of $-41.37M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$92.13M
$-42.35M
$12.17M
$79.96M
$131.40M
$-39.27M
$-1.49M
$-40.76M
$-40.76M
Income after Taxes
$-41.37M
$-41.37M
$-41.37M
$-41.37M
$-39.27M
$-39.02M
69.05M
69.05M
$-0.61
$-0.61
Balance Sheet Financials
$419.36M
$0.57M
$23.77M
$443.13M
$150.89M
--
$90.70M
$241.59M
$87.97M
$184.87M
$201.54M
69.31M
Cash Flow Statement Financials
$-56.40M
$54.96M
$-12.81M
$54.82M
$41.26M
$-13.56M
$74.18M
--
$-1.46M
Fundamental Metrics & Ratios
2.78
--
--
--
--
86.79%
-42.63%
-42.63%
--
-44.24%
-45.97%
$-56.90M
--
--
--
0.21
0.39
2.35
38.22
-47.03%
-22.38%
-9.34%
-20.53%
$2.91
$-0.82
$-0.82